COVID-19: Principles on Patient Access to Prescription Drugs
During this public health emergency, PBMs are committed to helping the patients we serve practice social distancing and stay at home safely with convenient, reliable access to their needed prescription drugs.
As patients evaluate their prescription drug needs, we are providing clinical services and other supports, and encourage patients to consult government guidance and, as needed, their health care providers.
All stakeholders in the prescription drug supply chain have an important role in balancing patient access and continuity of care now and avoiding drug shortages and supply disruptions in the future.
PBMs promote the following principles for enabling patient access and managing against supply chain disruptions.
- PBMs, other drug supply chain stakeholders and federal, state, and local government partners should work together to sustain access to care for patients and prevent drug shortages.
- PBMs recommend multiple approaches be made available that ensure patients have access to their prescription drugs now and in the days ahead, by balancing convenient, reliable access – such as home delivery and additional supply on hand – with the potential for drug shortages.
- PBMs recommend guidance from federal, state, and local government agencies that balances patients’ need to stay at home, the clinical appropriateness of supply for any given drug, and the need to prevent future drug shortages.
Promote Patient Access to Prescription Drugs
During this time of public health emergency, PBMs are taking action and recommending multiple approaches to help the patients we serve stay safely at home through reliable, convenient access to their needed prescription drugs.
- Facilitating reliable, convenient access to needed prescription drugs
- Promoting safety of patients and pharmacy staff
- Helping to keep the drug supply chain functioning well
- Promoting pharmacy staffing flexibility
- Focusing pharmacy audits on areas of greatest need